Bullous pemphigoid and internal diseases - A case-control study

European Journal of Dermatology

Volumn 20, Issue 1, 2010, Pages 96-101

  Jedlickova, Hana ^a   Hlubinka, Milos ^b   Pavlik, Tomas ^c   Semradova, Vera ^a   Budinska, Eva ^c   Vlasin, Zdenek ^b  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Bullous pemphigoid; Cancer; Diabetes mellitus; Etiopathogenesis; Neurological disorder

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BASAL CELL CARCINOMA; BLADDER CANCER; BREAST CANCER; BULLOUS PEMPHIGOID; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; COLON CANCER; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; GROUPS BY AGE; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE TEST; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MYCOSIS; NEUROFIBROMATOSIS; NEUROLOGIC DISEASE; PARAPROTEINEMIA; POLIOMYELITIS; POLYNEUROPATHY; PROSTATE CANCER; PROSTATE HYPERTROPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHIZOPHRENIA; SQUAMOUS CELL CARCINOMA; STOMACH CANCER;

AGED; AGED, 80 AND OVER; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NEOPLASMS; NERVOUS SYSTEM DISEASES; PEMPHIGOID, BULLOUS; PROSTATIC HYPERPLASIA;

EID: 76749163649     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.0805     Document Type: Article

References (45)

1. Jung M, Kippes W, Messer G, Zillikens D, Rzany B. Increased risk of bullous pemphigoid in male and very old patients: A populationbased study on incidence. J Am Acad Dermatol 1999; 41: 266-8.
2. Zillikens D, Wever S, Roth A, Weidenthaler-Barth B, Hashimoto T, Brocker EB. Incidence of Autoimmune Subepidermal Blistering Dermatoses in a Region of Central Germany. Arch Dermatol 1995; 131: 957-8.
3. Laffitte E, Borradori L. Bullous Pemphigoid: Clinical Features, Diagnostic Marker, and Immunopathogenic Mechanisms. In: M. Hertl, ed. Autoimmune diseases of the skin. Wien, NewYork: Springer, 2005, 71-93
4. Callen JP. Internal disorders associated with bullous disease of the skin. A critical review. J Am Acad Dermatol 1980; 3: 107-19.
5. Bastuji-Garin S, Joly P, Picard-Dahan C, et al. Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol 1996; 132: 272-6.
6. Foureur N, Descamps V, Lebrun-Vignes B, et al. Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid? Eur J Dermatol 2001; 11: 230-3.
7. Lee JJ, Downham 2nd TF. Furosemide-induced bullous pemphigoid: case report and review of literature. J Drugs Dermatol 2006; 5: 562-4.
8. Chuang TY, Korkij W, Soltani K, Clayman J, Cook J. Increased frequency of diabetes mellitus in patients with bullous pemphigoid: a case-control study. J Am Acad Dermatol 1984; 11: 1099-102.
9. th Congress of the EADV Prague. JEADV 2002; 16 (suppl 1): 24.
10. Rosina P, Chieregato C, D'Onghia FS. Bullous pemphigoid and diabetes mellitus. Acta Derm Venereol 1996; 76: 497-8.
11. Ablin J. Demonstration of Intercellular and Basement-Membrane Zone Antibodies in Benign Prostatic Hypertrophy. Dermatologica 1973; 146: 163-9.
12. Nagle RB, Hao J, Knox JD, Dalkin BL, Clark V, Cress AE. Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am J Pathol 1995; 146: 1498-507.
13. Venning VA, Wojnarowska F. The association of bullous pemphigoid and malignant disease: a case control study. Br J Dermatol 1990; 123: 439-45.
14. Rzany B, Danckwardt C, Jung M. Schuhmann, Messer G, Bayerl C. Erhöhtes Risiko von Malignom-erkrankungen bei Patienten mit bullösem Pemphigoid. Akt Dermatol 2000; 26: 53-9.
15. Antal AS, Grieb S, Homey B, et al. Paraneoplastic bullous pemphigoid in a 82-year-old man with breast and prostate carcinomas. Hautarzt 2007; 58: 833-4.
16. Muramatsu T, Iida T, Tada H, et al. Bullous pemphigoid associated with internal malignancies: identification of 180-kDa antigen by western immunoblotting. Br J Dermatol 1996; 135: 782-4.
17. Gül U, Kiliç A, Demirel O, Cakmak SK, Gönül M, Oksal A. Bullous pemphigoid associated with breast carcinoma. Eur J Dermatol 2006; 16: 581-2.
18. Oztürkcan S, Ermertcan AT, Sahin MT, Türkdogan P, Inanir I, Lekili M. Bullous pemphigoid associated with prostate adenocarcinoma. Indian J Dermatol Venereol Leprol 2004; 70: 39-41.
19. Iranzo P, Lopéz I, Robles MT, Mascaró Jr JM, Campo E, Herrero C. Bullous pemphigoid associated with mantle cell lymphoma. Arch Dermatol 2004; 140: 1496-9.
20. Misery L, Cambazard F, Rimokh R, et al. Bullous pemphigoid associated with chronic B-cell lymphatic leukaemia: the anti-230-kDa autoantibody is not synthesized by leukaemic cells. Br J Dermatol 1999; 141: 155-7.
21. Taniuchi K, Takata M, Matsui C, Fushida Y. Uchiyama, Mori T, Kawara S, Yancey K B, Takehara K. Antiepiligrin (laminin 5) cicatricial pemphigoid associated with an underlying gastric carcinoma producing laminin 5. Br J Dermatol 1999; 140: 696-700.
22. Uchiyama K, Yamamoto Y, Taniuchi K, Matsui C, Fushida Y, Shirao Y. Remission of antiepiligrin (laminin-5) cicatricial pemphigoid after excision of gastric carcinoma. Cornea 2000; 19: 564-6.
23. Fujimoto W, Ishida-Yamamoto A, Hsu R, et al. Anti-epiligrin cicatricial pemphigoid: a case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita. Br J Dermatol 1998; 139: 682-7.
24. Gibson GE, Daoud MS, Pittelkow MR. Anti-epiligrin (laminin 5) cicatricial pemphigoid and lung carcinoma: coincidence or association? Br J Dermatol 1997; 137: 780-2.
25. Matsushima S, Horiguchi Y, Honda T, et al. Yancey. A case of anti-epiligrin cicatricial pemphigoid associated with lung carcinoma and severe laryngeal stenosis: review of Japanese cases and evaluation of risk for internal malignancy. J Dermatol 2004; 31: 10-5.
26. Egan CA, Lazarova Z, Darling TN, Yee C, Coté T, Yancey KB. Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet 2001; 357: 1850-1.
27. Kirtschig G, Walkden VM, Venning VA, Wojnarowska F. Bullous pemphigoid and multiple sclerosis: a report of three cases and review of the literature. Clin Exp Dermatol 1995; 20: 449-53.
28. Masouyé I, Schmied E, Didierjean L, Abba Z, Saurat J-H. Bullous pemphigoid and multiple sclerosis: More than a coincidence? Report of three cases. J Am Acad Dermatol 1989; 21: 63-8.
29. Peramiquel L, Barnadas MA, Pimentel CL, et al. Bullous pemphigoid and multiple sclerosis: a report of two cases with ELISA test. EurJ Dermatol 2007; 17: 62-6.
30. Rácz A, Nagy É , Pályi I. Bullöses Pemphigoid bei einem Patienten mit multipler Sklerose und Psoriasis. H+G; 2000; 6: 369-72.
31. Chosidow O, Doppler V, Bensimon G, et al. Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease? Arch Dermatol 2000; 136: 521-4.
32. Yesudian PD, Wilson NJE, Parslew R. Bullous pemphigoid and neurofibromatosis-a chance association requiring special vigilance. Clinical and Experimental Dermatology 2000; 25: 658-9.
33. Bunker CB, Brown E. Unilateral bullous pemphigoid in a hemiplegic patient. Br J Dermatol 1993; 129: 502.
34. Long CC, Lever LR, Marks R. Unilateral bullous pemphigoid in a hemiplegic patient. Br J Dermatol 1992; 126: 614-6.
35. Tay YK, Cheong WK. An unusual case of localised pemphigoid. Ann Acad Med Singapore 1993; 22: 937-8.
36. Berthier M, Nasimi A, Boussemart T, Cardona J, Oriot D. Manifestations neurologiques chez un enfant de mére atteinte d'herpés gestationis. Arch Pediatr 1996; 3: 460-2.
37. Okumus N, Esra Önal E, Turkyilmaz C, et al. A Case Report of Neonatal Convulsions Due to Maternal Herpes Gestationis. Journal of Child Neurology 2007; 22: 488-91.
38. Brown A, Bernier G, Mathieu M, Rossant J, Kothary R. The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nat Genet 1995; 10: 301-6.
39. Laffitte E, Burkhard PR, Fontao L, et al. Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis? Br J Dermatol 2005; 152: 537-40.
40. Li L, Chen J, Wang B, Yao Y, Zuo Y. Sera from patients with bullous pemphigoid (BP) associated with neurological diseases recognized BP antigen 1 in the skin and brain. Br J Dermatol 2009; 160: 1343-5.
41. Seppänen A, Autio-Harmainen H, Alafuzoff I, et al. Collagen XVII is expressed in human CNS neurons. Mat Biol 2006; 25: 185-8.
42. Seppänen A, Pikkarainen M, Hartikainen P, Hofmann SC, Majamaa K, Alafuzoff I. Expression of collagen XVII and ubiquitinbinding protein p62 in motor neuron disease. Brain Research 2009; 1247: 171-7.
43. Foureur N, Mignot S, Senet P, et al. Correlation between the presence of type-2 anti-pemphigoid antibodies and dementia in elderly subjects with no clinical signs of pemphigoid. Ann Dermatol Venereol 2006; 133: 439-43.
44. Cordel N, Chosidow O, Hellot MF, et al. French Study Group of Bullous Diseases. Neurological disorders in patients with bullous pemphigoid. Dermatology 2007; 215: 187-91.
45. Stinco G, Codutti R, Scarbolo M, Valent F, Patrone P. A retrospective epidemiological study on the association of bullous pemphigoid and neurological diseases. Acta Derm Venereol 2005; 85: 136-9.